secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sotera Health Co (SHC)
CIK:        0001822479
Form:       8-K
Filed at:   2024-08-01T23:59:59+00:00
Accession:  0001822479-24-000036
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Sotera Health appoints Christopher A. Simon to board of directors
-----------------------------------------------------------------

- Board increased from 11 to 12 directors; Simon appointed as Class III director effective August 1, 2024.
- Simon is President & CEO of Haemonetics Corporation and will serve on the Leadership Development and Compensation Committee.
- Simon is independent under Nasdaq Rule 5605(a)(2); no arrangement or reportable transactions with the company.
- As non-employee director, Simon will receive standard cash retainer and annual restricted stock unit grant.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822479/000182247924000036/0001822479-24-000036-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822479/000182247924000036/shc-20240731.htm
  HTML page:      https://secwatch.observer/filing/0001822479-24-000036

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer